Skip to main content
. 2018 Apr 11;9:350. doi: 10.3389/fphar.2018.00350

Table 1.

Baseline characteristics of patients admitted to hospital wards.

Patients without ADRs No. 4,370 (%) Patients with ADRs during hospital stay No. 153 (%) p-value1 Patients hospitalized due to ADRs No. 296 (%) p-value2
Sex
    Females 2,189 (50.1) 89 (58.2) 0.049 188 (63.5) <0.001
    Males 2,181 (49.9) 64 (41.8) 108 (36.5)
    F/M ratio 1.0 1.4 1.7
Age median (Q1–Q3) 78.0 (65.0–84.0) 77.0 (64.0–84.0) 0.495 78.0 (68.0–85.0) 0.169
Age group
    <65 1,074 (24.6) 39 (25.5) 60 (20.3)
    65–78 1,228 (28.1) 47 (30.7) 89 (30.1)
    79–84 1,010 (23.1) 31 (20.3) 71 (24.0)
    >84 1,058 (24.2) 36 (23.5) 76 (25.7)
Most frequent comorbidities
    Diabetes mellitus 1,122 (25.7) 43 (28.1) 0.499 91 (30.7) 0.054
    Hypertension 964 (22.1) 48 (31.4) 0.007 90 (30.4) <0.001
    COPD 796 (18.2) 30 (19.6) 0.661 39 (13.2) 0.029
    Congestive cardiac failure 653 (14.9) 19 (12.4) 0.388 37 (12.5) 0.252
    Ischemic heart disease 336 (7.7) 11 (7.2) 0.820 33 (11.1) 0.033
    Arrhythmia 364 (8.3) 15 (9.8) 0.518 40 (13.5) 0.002
    Renal diseases 622 (14.2) 22 (14.4) 0.060 66 (22.3) <0.001
    Liver diseases 375 (8.6) 12 (7.8) 0.748 17 (5.7) 0.088
    Dementia 191 (4.4) 2 (1.3) 0.065 15 (5.1) 0.572
Charlson score, median (Q1–Q3) 1.0 (0.0–2.0) 1.0 (0.0–2.0) 0.856 1.0 (0.0–2.0) 0.105
No. drugs taken at admission, median (Q1–Q3) 4.0 (1.0–7.0) 5.0 (1.5–9.0) 0.002 6.0 (3.2–9.0) <0.001
No. drugs taken at admission
    <4 2,325 (53.2) 67 (43.8) 103 (34.8)
    5–9 1,691 (38.7) 60 (39.2) 139 (47.0)
    ≥10 354 (8.1) 26 (17.0) 54 (18.2)
LOS (days), median (Q1–Q3) 9.0 (6.0-13.0) 12.0 (8.0–17.0) <0.001 9.0 (6.0–12.0) 0.113

ADRs, adverse drug reactions; LOS, length of stay; COPD, chronic obstructive pulmonary disease. 1Patients with ADRs during hospital stay vs. patients without ADRs. 2Patients hospitalized due to ADRs vs. patients without ADRs.